Kidney Cancer
Axitinib (AG-013736) as Second Line Therapy for Metastatic Renal Cell Cancer: AXIS Trial
Trial ID: 08036
Contact: Mary A Rauch
Phone: (281)863-4681
Learn More about this trial.
go back | new search